KEYNOTE-122: Phase 2 study of pembrolizumab versus standard-of-care chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal carcinoma
Titel:
KEYNOTE-122: Phase 2 study of pembrolizumab versus standard-of-care chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal carcinoma
Auteur:
Ng, Q.S. Spreafico, A. Lee, V. Ngan, R.K.C. To, K.F. Ahn, M.-J. Hong, R.-L. Lin, J- C. Swaby, R.F. Chan, A.T.C.